A recent study demonstrates that amyloid-β (Aβ) can function as an antimicrobial peptide, and additional data show that bacteria and yeast can seed Aβ deposition into amyloid. These data suggest a complex interplay between the normal function of Aβ, its accumulation in the brain, and host immune defence.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The lexicon of antimicrobial peptides: a complete set of arginine and tryptophan sequences
Communications Biology Open Access 21 May 2021
-
Microbial involvement in Alzheimer disease development and progression
Molecular Neurodegeneration Open Access 24 July 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kumar, D. K. et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci. Transl. Med. 8, 340ra372 (2016).
Golde, T. E. The pathogenesis of Alzheimer's disease and the role of Aβ42. CNS Spectr. 12 (Suppl. 1), 4–6 (2007).
De Strooper, B., Vassar, R. & Golde, T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6, 99–107 (2010).
Soscia, S. J. et al. The Alzheimer's disease-associated amyloid β-protein is an antimicrobial peptide. PLoS ONE 5, e9505 (2010).
Kagan, B. L. et al. Antimicrobial properties of amyloid peptides. Mol. Pharm. 9, 708–717 (2012).
Xu, G. et al. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits. Acta Neuropathol. Commun. 3, 72 (2015).
Jucker, M. & Walker, L. C. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 70, 532–540 (2011).
Itzhaki, R. F. et al. Microbes and Alzheimer's disease. J. Alzheimers Dis. 51, 979–984 (2016).
Heneka, M. T., Golenbock, D. T. & Latz, E. Innate immunity in Alzheimer's disease. Nat. Immunol. 16, 229–236 (2015).
Jones, B. Alzheimer disease: TREM2 linked to late-onset AD. Nat. Rev. Neurol. 9, 5 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Golde, T. Host immune defence, amyloid-β peptide and Alzheimer disease. Nat Rev Neurol 12, 433–434 (2016). https://doi.org/10.1038/nrneurol.2016.105
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2016.105
This article is cited by
-
The lexicon of antimicrobial peptides: a complete set of arginine and tryptophan sequences
Communications Biology (2021)
-
Receptor for Advanced Glycation End Products (RAGE) Mediates Cognitive Impairment Triggered by Pneumococcal Meningitis
Neurotherapeutics (2021)
-
Microbial involvement in Alzheimer disease development and progression
Molecular Neurodegeneration (2020)
-
Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
CNS Drugs (2020)